Gene Silencing, Hormones, Pharma Companies and Trials

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Gene Silencing

Hormones

Pharma Companies

Trials

2020 review – Pharma’s progress outside of COVID-19

pharmaphorum

DECEMBER 23, 2020

The American Society of Clinical Oncology (ASCO) annual conference was one of the highlights of the year in cancer research and the fact it was held virtually did not distract from some stunning clinical lung cancer trial results presented by AstraZeneca. In the 500 patient trial, patients treated with Trodelvy lived for a median of 12.1

Marketing

Marketing Gene Silencing Gene Drugs

Unfolding The Folds Of Transthyretin

Delveinsight

AUGUST 6, 2020

Transthyretin (TTR) is a protein that the liver produces to facilitate the transfer of thyroid hormone and vitamin A in the blood. Gene-silencing Therapies. Silencing or modifying gene TTR aims to reduce the effect of both variant and wild-type TTR gene, thus reducing hepatic production by targeting its mRNA.

Gene Silencing

Gene Silencing Protein Marketing Gene

Clinical Research Informer

2020 review – Pharma’s progress outside of COVID-19

Unfolding The Folds Of Transthyretin

Stay Connected